Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease.
暂无分享,去创建一个
M. Eldar | M. Scheinowitz | V. Barak | S. Sclarovsky | D. Hasdai | S Sclarovsky | D Hasdai | M Scheinowitz | E Leibovitz | M Eldar | V Barak | E. Leibovitz | S. Sclarovsky,
[1] C. Thiemermann,et al. Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. , 1993, European journal of pharmacology.
[2] S. Takebayashi,et al. Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina. Histological data on 14 autopsied patients. , 1987, Atherosclerosis.
[3] Bridget Wilcken,et al. Pathogenesis of coronary artery disease , 1969 .
[4] G. Schreiner,et al. Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction. , 1990, Circulation research.
[5] Y. Hirata,et al. Induction of Nitric Oxide Synthase Gene by Interleukin‐1β in Cultured Rat Cardiocytes , 1994, Circulation.
[6] R. Thorpe,et al. Production and assay of the interleukins. , 1985, Journal of immunological methods.
[7] G. Montalescot,et al. Myocardial Viability in Patients With Q Wave Myocardial Infarction and No Residual Ischemia , 1992, Circulation.
[8] B. Giusti,et al. Transient Intermittent Lymphocyte Activation Is Responsible for the Instabilit of Angina , 1992, Circulation.
[9] N. Clausell,et al. Increased interleukin-1 beta and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets. , 1993, The American journal of pathology.
[10] D. Capuzzi,et al. Interleukin-1α As a Factor in Occlusive Vascular Disease , 1992 .
[11] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.
[12] V. Fuster,et al. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.
[13] G. Fantuzzi,et al. Cytokines in Acute Myocardial Infarction: Selective Increase in Circulating Tumor Necrosis Factor, Its Soluble Receptor, and Interleukin‐1 Receptor Antagonist , 1994, Journal of cardiovascular pharmacology.
[14] P. Libby,et al. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[15] A. Meager,et al. Assays for tumour necrosis factor and related cytokines. , 1989, Journal of immunological methods.
[16] C. Herzog. [Quantification of mRNA using the polymerase chain reaction--cytokines in rheumatoid arthritis]. , 1992, Schweizerische medizinische Wochenschrift.
[17] Lopes-Virella Mf. Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. , 1993 .
[18] J. Berman,et al. An endothelial cell adhesion protein for monocytes recognized by monoclonal antibody IG9. Expression in vivo in inflamed human vessels and atherosclerotic human and Watanabe rabbit vessels. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[19] P. Libby,et al. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. , 1986, The American journal of pathology.
[20] A. A. Taylor,et al. Inflammation in the course of early myocardial ischemia , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] P. Libby,et al. Inducible interleukin-1 gene expression in human vascular smooth muscle cells. , 1986, The Journal of clinical investigation.
[22] J. Norton,et al. Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats. , 1992, Surgery.
[23] N. Clausell,et al. In vivo blockade of tumor necrosis factor-alpha in cholesterol-fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation. , 1994, Circulation.
[24] M. Nobuyoshi,et al. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. , 1985, Circulation.
[25] N. Maulik,et al. Interleukin-1 alpha preconditioning reduces myocardial ischemia reperfusion injury. , 1993, Circulation.
[26] A. Hamsten. Hemostatic function and coronary artery disease. , 1995, The New England journal of medicine.
[27] C. Boutin,et al. Echocardiographic Follow‐up of Atrial Septal Defect After Catheter Closure by Double‐Umbrella Device , 1993, Circulation.
[28] G. Schreiner,et al. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Ross. The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.
[30] A. Harken,et al. Interleukin 1 pretreatment decreases ischemia/reperfusion injury. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[31] R. Cotran,et al. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells , 1984, The Journal of experimental medicine.
[32] C. Moyer,et al. Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis. , 1991, The American journal of pathology.
[33] D Schwartz,et al. A Cascade Model for Restenosis: A Special Case of Atherosclerosis Progression , 1992, Circulation.
[34] A. Matsumori,et al. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. , 1994, British heart journal.
[35] N. Clausell,et al. Upregulation of fibronectin synthesis by interleukin-1 beta in coronary artery smooth muscle cells is associated with the development of the post-cardiac transplant arteriopathy in piglets. , 1993, The Journal of clinical investigation.
[36] A. Pezzano,et al. C-reactive protein and serum amyloid A protein in unstable angina. , 1995, The New England journal of medicine.
[37] A. Maseri,et al. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. , 1982, British heart journal.
[38] H. Ishizaka,et al. Endothelium‐Derived Nitric Oxide as a Mediator of Acetylcholine‐Induced Coronary Vasodilation in Dogs , 1991, Journal of cardiovascular pharmacology.
[39] Michael V. Doyle,et al. Quantitation of mRNA by the Polymerase Chain Reaction , 1989 .
[40] C. Dinarello,et al. The role of interleukin-1 in disease. , 1993, The New England journal of medicine.
[41] K. Frei,et al. [Interleukin 1]. , 1985, Schweizerische medizinische Wochenschrift.
[42] A. Rebuzzi,et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. , 1994, The New England journal of medicine.
[43] S. Moncada,et al. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. , 1994, Immunology.
[44] D. Leszczyński,et al. IL‐1β‐Stimulated Leucocyte–Endothelial Adhesion is Regulated, in Part, by the Cyclic‐GMP‐Dependent Signal Transduction Pathway , 1994 .